New issues in Ethics and Oncology International and

New issues in Ethics and Oncology
520
505
506
Phys.Chemie
9
he
26
304
320
281
261 241
222
110
H
111
119 119
132
LIZ
105
2
112
P
<>
117
H
H
Jahnstraße
Uferstraße
r>
< Necka
ny
Hauptbahnhof
Copyright: Medienzentrum Universitätsklinikum Heidelberg http://www.uniklinikum-hd.de
H
P
27
30
17
18
19
20a
21
Bunsenplatz
H
he
Berg
r-
e
Adenau
Platz
P
Römerkreis
28
Blum
arstra
Neck
May 11 –im12
2012,
Heidelberg
aße
er Str
Römerstraße
<>
Ep
pe
lhe
Cz
er
im
br
üc
ke
-haus
Mittermaierstr.
Landfried
ID20600_Medienzentrum Universitätsklinikum Heidelberg
31
zstraße
Bergheimer Straße
22
36
alstr.
Vangerowstraße
r.
Weg
aße
Voßs29tr
aße
Wieblinge
r
P
25
26
Fehren
Bildungszentrum
im Heinsteinwerk
St
autstr
er
H
lle
Stadtha
H
ße
nstra
Sofieckar
Bism latz
P
eim
24
it
Hosp
nh
r.
anst
urm
Sch20 23a 35 23
Thib
an
Ernst-WalzBrücke
Stauwehr
M
i
enhe
Neu
100
UBA
Max-Planck-Institut
<> M
ann
Flugh heim
afe
A 656 n
Bismarcksäule
rTheodo
HeussBrücke
The organizers thank the German Research Foundation
(Deutsche Forschungsgemeinschaft DFG) for giving
a grant for the conference and Böhringer Ingelheim GmbH
for sponsoring.
P
223
DKFZ
UBA
221 220
130
133/
134
H
260 240
Kirschnerstraße
131
P
242
280
370
H
P
fstraße
Mönchho
Bunsengasse
P
e
rbach
ren
Nie
159
151
3
P
P
P
226
INF 306
ZMBH
282
Gästehaus
tell
hlstr.
162
m
tru
im
he
nn
Ma
153
156
Physik
243
Tumorvirologie
32
H
ks
mü
Schneid
360
9
Ta
n
Umweltphysik
229
H
Mensa
154
155
zen
0 Garten
34he
sc r
Botani
10
267
7051
Geogr.
Institut
Zoologisches
Institut
230
<> Ro
h
H
P
8
te
Luisenstr.
324
231
itu
Straße
305
325 Blutbank
344b
st
acher
LIZ 1 165
160
306
344a
INF 410
161
326
345
365
Med
Klin .
ik
346
In
Brückenstraße
ZOO
366
364
425
H
307
78
114
P
327
34
115
aße
nstr
410
347
-2
288
arte
367
11
Hörsaal
308
Mathem.
Institut
328
235
Rohrb
348
0
227
368
15
isc
234
Geologie
Hörsäle
Chemie
em
INF 366
INF 344a
INF 350
INF 670
INF 672
Speyerer Str. 4
INF 450
INF 671
INF 370/371
INF 346
INF 460
New issues in Ethics
and Oncology
15
International
and
16
32
multidisciplinary
expert meeting
34
37
e
straß
enthal
Blum
H
236
Mineralogie
252
Ch
27
P
253/
254
232
293/
292
Südasieninstitut
330
im
ss
H
Im Neuenheimer
Feld
H
H
H
Saturday,
12(INF)
May:
Heidelberg University Hospital,
P
P
Medical 400
Departments,
350 lecture hall,
12
450 Neuenheimer
Im
Feld
410,
69120
Heidelberg
1
Tierg
DJH
521
501
Bioquant
H
Mathematik URZ
294
37 460
430 3a
TSG
502
ße
P
523
Wohnheime
522
503
500
H
P
MPI für
Völkerrecht
535
stra
H
536
560
and
676 - 683
561
Pädagogische
Hochschule
INF 305
rL
ime
562
10
11
11a
12
13
14
524
504
17 Familientherapie
18 Frauenklinik (Pforte
19 Brustzentrum/ Onko
20 Arbeits-,Sozialmed
20a Klinische Sozialme
21 Medizinische Psych
22 Hautklinik
23 Rechts-,Verkehrsm
23a Rechts-,Verkehrsm
24 Psychiatrische Amb
25 Psychosomatische
26 Psychiatrische Klin
27 Prinzhornsammlung
28 Kinderpsychiatrie
29 Betriebsärztlicher D
30 Psychosom. Klinik/
31 Bildungszentrum
35 KKS
36 Allg.Med / Vers.fors
Institute for History and Ethics of Medicine
she
H
Medical Faculty Heidelberg
huh
ße
671
Venue
Friday, 1113
May: Theoretikum, lecture
hall 2,
Wohnheime
P
P
670
Im Neuenheimer672Feld
306,
69120
Heidelberg
14
P
DKFZ
P
530
Technologiepark 515
P
INF 400
INF 410
INF 153
INF 430
INF 131
INF 110
INF 220/221
INF 280
INF 324
dsc
nstra
P
Klinikum Bergh
Kopfklinik
Medizinische Klinik
Kinderklinik (alt)
Kinderklinik (Neubau)
Schmerzzentrum
Chirurgische Klinik
Pathologisches Institut
DKFZ
Hygieneinstitut
Institut für Immunologie
Med. Biometrie u. Informatik
Theoretikum
Institut für Humangenetik
Genetische Poliklinik
Otto Meyerhof Zentrum
VZM / Apotheke
Verwaltung / ZIM
ZIM
Ionentherapie/HIT
Zentrallabor
Gästehaus
Studiendekanat
NCT
Han
16
arte
Schwimmbad
581
582
516-519
Hubschrauberlandeplatz
Kla
Sportanlagen Universität
3
he
Tech
583
7050
700
Institut für Sport und
Sportwissenschaften
B
park
584
gie
nolo
HTC
1
2
3
3a
4
5
6
7
8
9
en
Olympiastützpunkt Rhein-Neckar
Bundesleistungszentrum
Berlinerstraße
P
H
Klinikum Neuenheim
Do
710
720
<<
Organisers
Institute for History and Ethics of Medicine,
Heidelberg University and
National Center for Tumor Diseases (NCT),
Heidelberg University Hospital
Contact
Prof. Dr. Monika Bobbert (+49 6221-545458) or
Dr. Beate Herrmann (+49 6221-5637922);
Institute for History and Ethics of Medicine,
Im Neuenheimer Feld 327
69120 Heidelberg
E-Mail: [email protected]
http://www.medgesch.uni-hd.de/
pfad
usen
Tierg
Main Speakers
Vihjalmur Arnason, Reykjavik
Monika Bobbert, Heidelberg
Wolfgang U. Eckart, Heidelberg
Doris Fölsch, Hallein
Hille Haker, Chicago
Mats G. Hansson, Uppsala
Beate Herrmann, Heidelberg
Frauke Ishorst-Witte, Hamburg
Patrick Jahn, Halle
Steven Joffe, Boston, Cambridge
Wolf Dieter Ludwig, Berlin
Oliver Rauprich, Bochum
Dorothy E. Roberts, Chicago
Jan Schildmann, Bochum
Thomas Strowitzki, Heidelberg
Antonella Surbone, New York, Rome
Ulrich Wedding, Jena
Eva Winkler, Heidelberg.
enstr
.
Archiv
t-Anl
Eber
rHich-
Fried
>>Sc
s>>
hlos
New issues in Ethics and Oncology
Friday 11 May 2012
Affordability of new cancer therapies:
the rationing debate in Oncology
9.00 - 09.20 Words of welcome, introduction
Communication & end-of-life decision making
9.20 - 10.00 Communication is the key:
can it be trained, taught and assessed?
Antonella Surbone, New York, Rome
10.00 - 10.40 Changing therapeutic targets?
Erbitux and Avastin as an example
Wolfgang U. Eckart, Heidelberg
10.40 - 10.55 Coffee break
10.55 - 11.35 Empirical and ethical aspects of tumor-specific
therapies in patients at an advanced stage
Eva Winkler, Heidelberg
11.35 - 12.15 Ethical criteria for treatment decisions in
critically ill cancer patients, who are no longer
capable of giving consent
Monika Bobbert, Beate Herrmann, Heidelberg
12.15 - 12.45 Ethical implications of terminally ill patients’
wishes to die: Why it is important to understand
the narratives
Kathrin Ohnsorge, Heike Gudat,
Christoph Rehmann-Sutter
12.45 - 14.00 Lunch
Individualized Medicine:
targeted therapies, biobanks and genomic analysis
14.00 - 14.40 Genetic testing in cancer therapy
Mats G. Hansson, Uppsala
14.40 - 15.20 Biobanks and genomic approaches to cancer
research: experiences from Iceland about
the problems of biobanks and genetic research
Vihjalmur Arnason, Reykjavik
15.20 - 15.50 Ethical aspects of individualized rectal cancer
therapy: the relevance of socioempirical
findings regarding physicians’ risk assessment
S. Wöhlke, A. Hessling,
S. Schicktanz, Göttingen
15.50 - 16.10 Coffee break
16.10 - 16.50 Is there rationing in cancer care?
Jan Schildmann, Bochum
16.50 - 17.30 Qualitative interview study on rationing debate
and ethical analysis
Oliver Rauprich, Bochum
Nursing care in oncology
17.30 - 18.10 Ethical issues of oncology nursing (overview)
Doris Fölsch, Hallein (Austria)
18.10 - 18.50 Standards of Care in Oncology
Patrick Jahn, Halle
Saturday 12 May 2012
Vulnerable patient groups
9.00 - 9.40
9.40 - 10.20
10.20 - 10.40
10.40 - 11.10
11.10 - 11.40
11.40 - 13.00
Challenges in the care of homeless
cancer patients
Frauke Ishorst-Witte, Hamburg
The care of cancer patients in view of human
vulnerability
Hille Haker, Chicago
Coffee break
Duties of children? Ethical aspects of the
well-being of minors who donate blood stem
cells to their siblings
Christina Schües, Lübeck
Children’s interests and rights between
the doctor, the parents and the state
Christoph Schickhardt, Düsseldorf
Lunch
Fertility preservation
13.00 - 13.40 Medical and ethical issues of new forms of
fertility preservation in cancer patients
Thomas Strowitzki, Heidelberg
13.40 - 14.20 Ethical and legal questions in the emerging
field of oncofertility
Dorothy E. Roberts, Chicago
14.20 - 14.50 Discussion of a key-concept of ethics using
the example of fertility preservation in young
cancer patients
Bettina Boettcher, Innsbruck
14.50 - 15.10 Coffee break
15.10 - 15.50 Ethical issues in geriatric oncology
Ulrich Wedding, Jena
Clinical cancer research: opportunities, risks, perspectives
15.50 - 16.30 Frequency and effects of conflicts of interest
in clinical trials
Steven Joffe, Boston, Cambridge
16.30 - 17.10 Evidence and ethics in oncological trials
Wolf Dieter Ludwig, Berlin
17.10 - 17.50 Benefit-risk-assessment and informed
consent from patients in clinical research
Steven Joffe, Boston, Cambridge
17.50 - 18.00 Conclusions, conference’s end